DexCom
DXCM
457 hedge funds and large institutions have $10.6B invested in DexCom in 2019 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 146 increasing their positions, 169 reducing their positions, and 35 closing their positions.
126% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 35
48% more call options, than puts
Call options by funds: $92.9M | Put options by funds: $62.7M
10% more funds holding
Funds holding: 415 → 457 (+42)
0% less capital invested
Capital invested by funds: $10.6B → $10.6B (-$10.1M)
3.04% less ownership
Funds ownership: 397.57% → 394.52% (-3%)
14% less repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 169
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$292M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$240M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$88.8M |
| 4 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
+$82M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$68.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$222M |
| 2 |
HM
HealthCor Management
New York
|
-$104M |
| 3 |
JP Morgan Chase
New York
|
-$93.3M |
| 4 |
Two Sigma Investments
New York
|
-$87.7M |
| 5 |
Morgan Stanley
New York
|
-$63.8M |
DXCM Hedge Fund Activity: Q1 2019 in Review
457 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2019, worth a combined $10.6B — down 0.1% from $10.6B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new DXCM positions and 35 closed out — a net gain of 44 holders — while 146 added to existing stakes and 169 trimmed.
The largest buyer was Capital World Investors, adding an estimated $292M. The largest seller was Wellington Management Group, cutting an estimated $222M.
- 457 institutional investors held DexCom (DXCM) as of Q1 2019, up from 415 in Q4 2018.
- Funds reported $10.6B of DexCom stock for Q1 2019, down 0.1% quarter-over-quarter.
- 79 funds opened new DexCom positions in Q1 2019 and 35 closed out, a net change of +44 holders.
- The largest DexCom buyer in Q1 2019 was Capital World Investors, an estimated $292M added.
- The largest DexCom seller in Q1 2019 was Wellington Management Group, an estimated $222M sold.
Based on aggregated 13F filings for Q1 2019.